Cosentyx snrdy 300MG dose-2PENML
Ended Awarded
- Contract number
- SPE2DB25FXG99
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,399
Award facts
- Contract value 100% obligated
- $30,398.83 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Cosentyx (secukinumab) 300mg dose in 2-pen/mL formulation, valued at $30,398.83. This is a firm fixed price delivery order with no set-aside designation, competitively awarded under what appears to be the DLA Troop Support Medical's Indefinite Delivery Contract (IDC) valued at $999,999,999.00 through December 2026. The ultimate completion date for this order is September 12, 2025, with performance fulfillment at AmerisourceBergen's facility in Conshohocken, Pennsylvania.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider headquartered in Conshohocken, serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's primary IDC with DLA Troop Support Medical functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products, brand-name and generic medications, vaccines, and medical supplies to support military healthcare programs worldwide. This specific delivery order represents one of numerous pharmaceutical procurements fulfilling the DLA's medical supply chain requirements across multiple therapeutic domains and operational needs.
Quick answers
Who was awarded contract SPE2DB25FXG99?
SPE2DB25FXG99 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 11, 2025.
How much is contract SPE2DB25FXG99 worth?
The government has obligated $30,399 on SPE2DB25FXG99.
Is contract SPE2DB25FXG99 an order under another contract?
Yes. SPE2DB25FXG99 is a delivery order under SPE2DB22D3501, an indefinite delivery contract.
Was contract SPE2DB25FXG99 competed?
The extent of competition for SPE2DB25FXG99 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award